Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Biochimica Et Biophysica Acta|June 15, 2007
Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedureAlexander Berchanski, Aviva LapidotProteins|November 25, 2003
Construction of molecular assemblies via docking: modeling of tetramers with D2 symmetryAlexander Berchanski, Miriam EisensteinBioconjugate Chemistry|August 21, 2008
Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugatesAlexander Berchanski, Aviva LapidotJournal of Molecular Modeling|December 6, 2008
Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sitesAlexander Berchanski, Aviva LapidotProteins|May 27, 2004
Hydrophobic complementarity in protein-protein dockingAlexander Berchanski, Boaz Shapira, Miriam EisensteinThe FEBS Journal|September 23, 2008
Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcriptionAviva Lapidot, Alexander Berchanski, Gadi BorkowProteins|June 28, 2005
Modeling oligomers with Cn or Dn symmetry: application to CAPRI target 10Alexander Berchanski, Dadi Segal, Miriam EisensteinThe FEBS Journal|November 22, 2007
Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugatesRavi Hegde, Gadi Borkow, Alexander Berchanski, et al.The FEBS Journal|September 14, 2011
Insights into the mechanism of enhanced mobilization of hematopoietic progenitor cells and release of CXCL12 by a combination of AMD3100 and aminoglycoside-polyarginine conjugatesAlexander Berchanski, Alexander Kalinkovich, Aya Ludin, et al.Proteins|June 5, 2003
Prediction of the unknown: inspiring experience with the CAPRI experimentEfrat Ben-Zeev, Alexander Berchanski, Alexander Heifetz, et al.Pageof 2